Biocare Medical Launches 3 Novel IVD Antibodies for Clinical Diagnostic and Cancer Research: BAP1, BCA-225 [Cu-18] and SMAD4 [EP618Y]

Biocare Medical, a leading provider of innovative, automated immunohistochemistry (IHC) reagents and instrumentation, announces the launch of three novel IVD IHC antibody markers at the forefront of clinical diagnostic and research applications. These three markers SMAD4 [EP618Y], BAP1, and BCA-225 [Cu-18] may aid pathologists in critical prognostic and diagnostic decisions – impacting patient outcome. Each […]

Email Cart